Gut Microbiota in Primary Sclerosing Cholangitis: From Prognostic Role to Therapeutic Implications
Digestive Diseases · 2024 · 42 (4) · 369-379
DOI: 10.1159/000538493 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Digestive Diseases, online erschienen am 25.03.2024. Verfasst von Valeria Maccauro und 3 weiteren Autor:innen. Beteiligte Einrichtung: Liver Diseases Unit, CEMAD Centro Malattie dell'Apparato Digerente, Fondazione Policlinico Universitario Gemelli IRCCS, Rome, Italy. Hauptthemen laut MEDLINE: Cholangitis, Sclerosing, Gastrointestinal Microbiome. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 79 Literaturangaben.
Abstract (Originalsprache)
Background: Primary sclerosing cholangitis (PSC) is a chronic cholestatic disease of unknown etiology characterized by biliary inflammation and periductal fibrosis. The gut microbiota plays a crucial role in the pathogenesis of PSC by regulating bile acid metabolism, inflammation, and immune response. On the other hand, liver disease progression affects the composition of the gut microbiota, fostering these mechanisms in a mutual detrimental way. Summary: Recent evidences described a specific pro-inflammatory microbial signature in PSC patients, with an overall reduced bacterial diversity and the loss of beneficial metabolites such as short-chain fatty acids. As effective therapies for PSC are still lacking, targeting the gut microbiota offers a new perspective in the management of this disease. To date, antibiotics, fecal microbiota transplantation, and probiotics are the most studied gut microbiota-targeted intervention in PSC, but new potential strategies such as vaccines and bacteriophages represent possible future therapeutic horizons. Key Messages: In this review, we focus on the role of the gut microbiota in PSC, considering its pathogenetic and prognostic role and the therapeutic implications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Liver Diseases Unit, CEMAD Centro Malattie dell'Apparato Digerente, Fondazione Policlinico Universitario Gemelli IRCCS, Rome, Italy.
- Dipartimento di Medicina e Chirurgia Traslazionale, Università Cattolica del Sacro Cuore, Rome, Italy.
- Liver Diseases Unit, CEMAD Centro Malattie dell'Apparato Digerente, Fondazione Policlinico Universitario Gemelli IRCCS, Rome, Italy, francesca.ponziani@gmail.com.
- Dipartimento di Medicina e Chirurgia Traslazionale, Università Cattolica del Sacro Cuore, Rome, Italy, francesca.ponziani@gmail.com.
Zitieren
APA
Maccauro, V., Fianchi, F., Gasbarrini, A., & Ponziani, F. R. (2024). Gut Microbiota in Primary Sclerosing Cholangitis: From Prognostic Role to Therapeutic Implications. Digestive Diseases, 42(4), 369-379. https://doi.org/10.1159/000538493
Vancouver
Maccauro V, Fianchi F, Gasbarrini A, Ponziani FR. Gut Microbiota in Primary Sclerosing Cholangitis: From Prognostic Role to Therapeutic Implications. Digestive Diseases. 2024;42(4):369-379. doi:10.1159/000538493
BibTeX
@article{Maccauro2024,
author = {Maccauro, Valeria and Fianchi, Francesca and Gasbarrini, Antonio and Ponziani, Francesca Romana},
title = {Gut Microbiota in Primary Sclerosing Cholangitis: From Prognostic Role to Therapeutic Implications},
journal = {Digestive Diseases},
year = {2024},
volume = {42},
number = {4},
pages = {369--379},
doi = {10.1159/000538493}
}
EUVIMED